Technology areas: Biotechnology & Pharmaceuticals • Communications
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Nantes Université has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct art units and involve 3 distinct examiners. This distribution means that each of the 3 pending actions is being reviewed by a different person in a different technical group. The one-to-one ratio between pending actions and examiners indicates that no single official oversees a majority of the university's current prosecution.
The busiest examiner is CASCAIS, JUSTIN PHILIP, who is responsible for 1 pending office action. With 3 pending actions and 3 distinct examiners, there is no concentration of workload under a single individual. The involvement of 3 distinct art units for only 3 actions highlights the diverse technical classifications of the university's biotechnology filings. Practitioners must manage 3 separate tracks of communication across 3 different specialized groups at the patent office. This decentralized structure requires a tailored approach for each of the 3 pending matters, as they are being handled by distinct examiners in different administrative units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CASCAIS, JUSTIN PHILIP | 1 | 72.3% | +6.5% |
| DENT, ALANA HARRIS | 1 | 44.1% | +32.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18878699 | METHOD FOR RECOGNIZING BIFURCATIONS IN A VASCULAR TREE, ASSOCIATED METHODS AND DEVICES | CASCAIS, JUSTIN PHILIP | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555093 | NEW METHOD TO IMPROVE THE ANTI-TUMORAL ACTIVITY OF MACROPHAGES | DENT, ALANA HARRIS | — |
| Art Unit | Apps |
|---|---|
| 2668 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18878699 | METHOD FOR RECOGNIZING BIFURCATIONS IN A VASCULAR TREE, ASSOCIATED METHODS AND DEVICES | CASCAIS, JUSTIN PHILIP | 2668 | §101§103 | Non-Final OA | — | Pending | Dec 24, 2024 |
| 18555093 | NEW METHOD TO IMPROVE THE ANTI-TUMORAL ACTIVITY OF MACROPHAGES | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | — | Pending | Oct 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNantes Université has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Justin Philip Cascais has the most, with 1 of Nantes Université's pending office actions.
Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.
